Modules | Diabetes

On-demand MEDTalks: Beyond HbA1c: A new era in type 2 diabetes management

EA hours: 1
MO hours:
RP hours:
Total hours: 1
New york city street with sun rise coming through the buildings
On this page
    For years, type 2 diabetes management in Australia has centred around treating to glycaemic targets, particularly HbA1c - a reactive approach that often waited for failure before adjusting treatment. But the paradigm has shifted with recent changes to the PBS. We're now embracing a ‘treat to prevent’ model, focusing on early interventions to prevent cardiovascular and kidney complications in appropriate patients before they occur.
    In this MEDTalks - a fast-paced, short-format style presentation - our four clinical experts will unpack current implications of this approach in primary care, including recent PBS updates on access to key type 2 diabetes medications. Join us to gain important insights and practical strategies for delivering patient-centred care that looks beyond HbA1c.

    Learning outcomes

    By completing this learning activity, participants will be able to:
    Rationalise the limitations of a HbA1c-focused approach in the management of type 2 diabetes and its evolution.
    Describe the principles of a ‘treat to prevent’ model and its relevance to cardiovascular and renal risk reduction.
    Apply evidence-based prescribing strategies to optimise long-term outcomes for patients with type 2 diabetes.
    Interpret recent PBS changes and their implications for initiation of SGLT2 inhibitors and GLP-1 receptor agonists.
    New activity

    This activity was filmed at GPCE Melbourne in July 2025

    Speakers

    A/Prof Gary Kilov
    A/Prof Gary Kilov AM
    MBBCh

    GP, Tasmania
    Clinical Associate Professor, University of Melbourne.  Widely published in peer reviewed journals on topics covering diabetes, obesity and respiratory medicine.

    Dr Rochelle Sleaby
    Dr Rochelle Sleaby

    GP with an interest in translating data and digital health intervention research to diabetes care and prevention.  PHD candidate investigating precision diabetes at University of Melbourne and Australian Centre for Accelerating Diabetes Innovations (ACADI).

    Professor Jonathan Shaw
    Prof Jonathan Shaw

    Endocrinologist and Deputy Director at Melbourne’s Baker Heart and Diabetes Institute
    Focus on epidemiology and clinical research in diabetes.  Highly-cited author of over 500 peer-reviewed scientific papers.

    Conjoint A/Prof Chee Khoo
    Conjoint Associate Professor Chee Khoo
    M.B.,B.S. Hons.

    GP, Ingleburn, NSW
    Chair of the Education Working Group at the Diabetes, Obesity and Metabolism Translational Research Unit (DOMTRU).  Member of the RACGP’s Special Interest Groups in Diabetes and Obesity Management.

    On-demand MEDTalks: Beyond HbA1c - Education
    On-demand MEDTalks: Beyond HbA1c - Evaluation
    Sponsored by

    AstraZeneca Australia

    RACGP and ACRRM CPD logo

    Related content

    Obese man asleep on the lounge
    Modules
    EA: 2.5
    MO: 0
    RP: 0.5
    Total: 3
    A wake-up call: Diagnosing and managing OSA in primary care
    knight in armour with shield and sword
    Audits
    EA: 1.5
    MO: 4
    RP: 1
    Total: 6.5
    Clinical audit: An update on organ protection in T2D: focus on cardiorenal disease
    Obese man having his waist circumference measured
    Advanced courses
    EA: 4
    MO: 2
    RP: 1.5
    Total: 7.5
    Chronic weight management: How low should you go?
    Overweight lady in consultation with doctor
    Modules
    EA: 1
    MO: 0
    RP: 0
    Total: 1
    On-demand webinar: Pharmacotherapy for overweight and obesity